The human touch matters when developing treatments. The Fast Company Impact Council is an invitation-only membership ...

In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus ...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a ...

Tarsus Pharmaceuticals (NASDAQ:TARS) has pared some of an earlier gain of as much as 13% and is now up 8% amid a report that ...

Tarsus Pharmaceuticals, Inc. announced a live webcast scheduled for May 1, 2025, at 1:30 p.m. PT to discuss its financial results for the first quarter of 2025 and provide a corporate update. The ...

Tarsus Pharmaceuticals (NASDAQ ... These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns ...

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a ...